• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类钙调蛋白基因的基因组结构。

Genomic structure of the human caldesmon gene.

作者信息

Hayashi K, Yano H, Hashida T, Takeuchi R, Takeda O, Asada K, Takahashi E, Kato I, Sobue K

机构信息

Department of Neurochemistry and Neuropharmacology, Osaka University Medical School, Japan.

出版信息

Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12122-6. doi: 10.1073/pnas.89.24.12122.

DOI:10.1073/pnas.89.24.12122
PMID:1465449
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC50710/
Abstract

The high molecular weight caldesmon (h-CaD) is predominantly expressed in smooth muscles, whereas the low molecular weight caldesmon (l-CaD) is widely distributed in nonmuscle tissues and cells. The changes in CaD isoform expression are closely correlated with the phenotypic modulation of smooth muscle cells. During a search for isoform diversity of human CaDs, l-CaD cDNAs were cloned from HeLa S3 cells. HeLa l-CaD I is composed of 558 amino acids, whereas 26 amino acids (residues 202-227 for HeLa l-CaD I) are deleted in HeLa l-CaD II. The short amino-terminal sequence of HeLa l-CaDs is different from that of fibroblast (WI-38) l-CaD II and human aorta h-CaD. We have also identified WI-38 l-CaD I, which contains a 26-amino acid insertion relative to WI-38 l-CaD II. To reveal the molecular events of the expressional regulation of the CaD isoforms, the genomic structure of the human CaD gene was determined. The human CaD gene is composed of 14 exons and was mapped to a single locus, 7q33-q34. The 26-amino acid insertion is encoded in exon 4 and is specifically spliced in the mRNAs for both h-CaD and l-CaDs I. Exon 3 is the exon that encodes the central repeating domain specific to h-CaD (residues 208-436) together with the common domain in all CaD (residues 73-207 for h-CaD and WI-38 l-CaDs, and residues 68-201 for HeLa l-CaDs). The regulation of h- and l-CaD expression is thought to depend on selection of the two 5' splice sites within exon 3. Thus, the change in expression between l-CaD and h-CaD might be caused by this splicing pathway.

摘要

高分子量钙调蛋白(h-CaD)主要在平滑肌中表达,而低分子量钙调蛋白(l-CaD)广泛分布于非肌肉组织和细胞中。CaD亚型表达的变化与平滑肌细胞的表型调节密切相关。在寻找人类CaD的亚型多样性过程中,从HeLa S3细胞中克隆了l-CaD cDNA。HeLa l-CaD I由558个氨基酸组成,而HeLa l-CaD II中缺失了26个氨基酸(HeLa l-CaD I的202-227位残基)。HeLa l-CaD的短氨基末端序列与成纤维细胞(WI-38)l-CaD II和人主动脉h-CaD的不同。我们还鉴定出了WI-38 l-CaD I,相对于WI-38 l-CaD II,它含有一个26个氨基酸的插入片段。为了揭示CaD亚型表达调控的分子事件,确定了人类CaD基因的基因组结构。人类CaD基因由14个外显子组成,定位于一个单一基因座7q33-q34。26个氨基酸的插入片段在外显子4中编码,并且在h-CaD和l-CaD I的mRNA中特异性剪接。外显子3是编码h-CaD特有的中央重复结构域(208-436位残基)以及所有CaD中的共同结构域(h-CaD和WI-38 l-CaD的73-207位残基,HeLa l-CaD的68-201位残基)的外显子。h-CaD和l-CaD表达的调控被认为取决于外显子3内两个5'剪接位点的选择。因此,l-CaD和h-CaD之间表达的变化可能是由这种剪接途径引起的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5803/50710/21afc6312643/pnas01098-0487-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5803/50710/f0d48f83fb8b/pnas01098-0484-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5803/50710/65f02f31ea91/pnas01098-0485-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5803/50710/90326359d65b/pnas01098-0487-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5803/50710/21afc6312643/pnas01098-0487-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5803/50710/f0d48f83fb8b/pnas01098-0484-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5803/50710/65f02f31ea91/pnas01098-0485-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5803/50710/90326359d65b/pnas01098-0487-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5803/50710/21afc6312643/pnas01098-0487-b.jpg

相似文献

1
Genomic structure of the human caldesmon gene.人类钙调蛋白基因的基因组结构。
Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12122-6. doi: 10.1073/pnas.89.24.12122.
2
Common structural and expressional properties of vertebrate caldesmon genes.脊椎动物钙调蛋白基因的常见结构和表达特性。
Biochem Biophys Res Commun. 1993 Nov 30;197(1):145-53. doi: 10.1006/bbrc.1993.2453.
3
Structural and functional relationships between h- and l-caldesmons.
J Biol Chem. 1991 Jan 5;266(1):355-61.
4
Specific disruption of smooth muscle caldesmon expression in mice.小鼠平滑肌钙调蛋白表达的特异性破坏。
Biochem Biophys Res Commun. 2005 May 20;330(4):1132-7. doi: 10.1016/j.bbrc.2005.03.089.
5
Caldesmon isoform associated with phenotypic modulation of mesangial cells.与系膜细胞表型调节相关的钙调蛋白异构体。
Exp Nephrol. 2000 Jan-Feb;8(1):20-7. doi: 10.1159/000020644.
6
Characterization of cDNA clones encoding a human fibroblast caldesmon isoform and analysis of caldesmon expression in normal and transformed cells.编码人成纤维细胞钙调蛋白异构体的cDNA克隆的鉴定及正常细胞和转化细胞中钙调蛋白表达的分析。
J Biol Chem. 1991 Sep 5;266(25):16917-24.
7
Differential expression of Hela-type caldesmon in tumour neovascularization: a new marker of angiogenic endothelial cells.海拉型钙调蛋白在肿瘤新生血管形成中的差异表达:血管生成内皮细胞的一种新标志物。
J Pathol. 2005 Feb;205(3):408-14. doi: 10.1002/path.1700.
8
Caldesmon mRNA splicing and isoform expression in mammalian smooth-muscle and non-muscle tissues.哺乳动物平滑肌和非肌肉组织中钙调蛋白mRNA剪接及同工型表达
Biochem J. 1995 Jan 15;305 ( Pt 2)(Pt 2):445-50. doi: 10.1042/bj3050445.
9
Coordinate expression of alpha-tropomyosin and caldesmon isoforms in association with phenotypic modulation of smooth muscle cells.α-原肌球蛋白与钙调蛋白亚型的协同表达与平滑肌细胞的表型调节相关。
J Biol Chem. 1997 Jun 13;272(24):15396-404. doi: 10.1074/jbc.272.24.15396.
10
Alternative splicing of exons encoding the calmodulin-binding domains and C termini of plasma membrane Ca(2+)-ATPase isoforms 1, 2, 3, and 4.编码质膜Ca(2+) -ATP酶同工型1、2、3和4的钙调蛋白结合结构域及C末端的外显子的可变剪接
J Biol Chem. 1993 Feb 5;268(4):2740-8.

引用本文的文献

1
XTP8 Promotes Ovarian Cancer Progression by Activating AKT/AMPK/mTOR Pathway to Regulate EMT.XTP8 通过激活 AKT/AMPK/mTOR 通路调控 EMT 促进卵巢癌进展。
Cell Biochem Biophys. 2024 Jun;82(2):945-957. doi: 10.1007/s12013-024-01246-4. Epub 2024 Mar 13.
2
Glucocorticoid receptor-induced non-muscle caldesmon regulates metastasis in castration-resistant prostate cancer.糖皮质激素受体诱导的非肌肉钙调蛋白调节去势抵抗性前列腺癌的转移。
Oncogenesis. 2023 Aug 12;12(1):42. doi: 10.1038/s41389-023-00485-z.
3
Immunohistochemical Expression Analysis of Caldesmon Isoforms in Colorectal Carcinoma Reveals Interesting Correlations with Tumor Characteristics.

本文引用的文献

1
Are snRNPs involved in splicing?小核核糖核蛋白颗粒参与剪接过程吗?
Nature. 1980 Jan 10;283(5743):220-4. doi: 10.1038/283220a0.
2
A catalogue of splice junction sequences.剪接连接序列目录。
Nucleic Acids Res. 1982 Jan 22;10(2):459-72. doi: 10.1093/nar/10.2.459.
3
Purification of a calmodulin-binding protein from chicken gizzard that interacts with F-actin.从鸡砂囊中纯化一种与F-肌动蛋白相互作用的钙调蛋白结合蛋白。
免疫组织化学分析结蛋白同工型在结直肠癌中的表达揭示了与肿瘤特征的有趣相关性。
Int J Mol Sci. 2023 Jan 23;24(3):2275. doi: 10.3390/ijms24032275.
4
Emerging role of caldesmon in cancer: A potential biomarker for colorectal cancer and other cancers.钙调蛋白在癌症中的新作用:结直肠癌及其他癌症的潜在生物标志物
World J Gastrointest Oncol. 2022 Sep 15;14(9):1637-1653. doi: 10.4251/wjgo.v14.i9.1637.
5
CALD1 promotes the expression of PD-L1 in bladder cancer via the JAK/STAT signaling pathway.CALD1通过JAK/STAT信号通路促进膀胱癌中PD-L1的表达。
Ann Transl Med. 2021 Sep;9(18):1441. doi: 10.21037/atm-21-4192.
6
CALD1 Modulates Gliomas Progression via Facilitating Tumor Angiogenesis.CALD1通过促进肿瘤血管生成调节胶质瘤进展。
Cancers (Basel). 2021 May 30;13(11):2705. doi: 10.3390/cancers13112705.
7
Weighted Gene Co-expression Network Analysis Identifies CALD1 as a Biomarker Related to M2 Macrophages Infiltration in Stage III and IV Mismatch Repair-Proficient Colorectal Carcinoma.加权基因共表达网络分析确定CALD1为与III期和IV期错配修复功能正常的结直肠癌中M2巨噬细胞浸润相关的生物标志物。
Front Mol Biosci. 2021 Apr 29;8:649363. doi: 10.3389/fmolb.2021.649363. eCollection 2021.
8
Proteomic analysis of Medulloblastoma reveals functional biology with translational potential.对髓母细胞瘤的蛋白质组学分析揭示了具有转化潜力的功能生物学。
Acta Neuropathol Commun. 2018 Jun 7;6(1):48. doi: 10.1186/s40478-018-0548-7.
9
Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer.钙调蛋白的过表达与原发性非肌层浸润性膀胱癌患者的肿瘤进展相关。
Oncotarget. 2015 Nov 24;6(37):40370-84. doi: 10.18632/oncotarget.5458.
10
cGMP-dependent protein kinase Iβ regulates breast cancer cell migration and invasion via interaction with the actin/myosin-associated protein caldesmon.cGMP 依赖性蛋白激酶 Iβ 通过与肌动球蛋白相关蛋白钙调蛋白相互作用调节乳腺癌细胞迁移和侵袭。
J Cell Sci. 2013 Apr 1;126(Pt 7):1626-36. doi: 10.1242/jcs.118190. Epub 2013 Feb 15.
Proc Natl Acad Sci U S A. 1981 Sep;78(9):5652-5. doi: 10.1073/pnas.78.9.5652.
4
Occurrence of caldesmon (a calmodulin-binding protein) in cultured cells: comparison of normal and transformed cells.钙调蛋白(一种钙调素结合蛋白)在培养细胞中的出现:正常细胞与转化细胞的比较。
Proc Natl Acad Sci U S A. 1984 May;81(10):3133-7. doi: 10.1073/pnas.81.10.3133.
5
Transcription and RNA processing by the DNA tumour viruses.DNA肿瘤病毒的转录与RNA加工
Nature. 1980 Oct 9;287(5782):491-9. doi: 10.1038/287491a0.
6
A mechanism for RNA splicing.一种RNA剪接机制。
Proc Natl Acad Sci U S A. 1980 Apr;77(4):1877-9. doi: 10.1073/pnas.77.4.1877.
7
Segmental distribution of bithorax complex proteins during Drosophila development.果蝇发育过程中双胸复合体蛋白的节段性分布。
Nature. 1985;313(6003):545-51. doi: 10.1038/313545a0.
8
Identification by monoclonal antibodies and characterization of human platelet caldesmon.通过单克隆抗体鉴定及对人血小板钙调蛋白的特性分析
J Cell Biol. 1986 May;102(5):1748-57. doi: 10.1083/jcb.102.5.1748.
9
Caldesmon: a common actin-linked regulatory protein in the smooth muscle and nonmuscle contractile system.钙调蛋白:平滑肌和非肌肉收缩系统中一种常见的肌动蛋白连接调节蛋白。
J Cell Biochem. 1988 Jul;37(3):317-25. doi: 10.1002/jcb.240370306.
10
Expression of high and low molecular weight caldesmons during phenotypic modulation of smooth muscle cells.平滑肌细胞表型调节过程中高分子量和低分子量钙调蛋白的表达
Proc Natl Acad Sci U S A. 1987 Dec;84(24):9049-53. doi: 10.1073/pnas.84.24.9049.